Literature DB >> 25098539

A novel TFG mutation causes Charcot-Marie-Tooth disease type 2 and impairs TFG function.

Pei-Chien Tsai1, Yen-Hua Huang1, Yuh-Cherng Guo1, Hung-Ta Wu1, Kon-Ping Lin1, Yu-Shuen Tsai1, Yi-Chu Liao1, Yo-Tsen Liu1, Tze-Tze Liu1, Lung-Sen Kao1, Shaw-Fang Yet1, Ming-Ji Fann1, Bing-Wen Soong2, Yi-Chung Lee2.   

Abstract

OBJECTIVE: To describe a novel mutation in TRK-fused gene (TFG) as a new cause of dominant axonal Charcot-Marie-Tooth disease (CMT) identified by exome sequencing and further characterized by in vitro functional studies.
METHODS: Exome sequencing and linkage analysis were utilized to investigate a large Taiwanese family with a dominantly inherited adult-onset motor and sensory axonal neuropathy in which mutations in common CMT2-implicated genes had been previously excluded. Functional effects of the mutant gene products were investigated in vitro.
RESULTS: Exome sequencing of 2 affected individuals in this family revealed a novel heterozygous mutation, c.806G>T (p.Gly269Val), in TFG that perfectly cosegregates with the CMT2 phenotype in all 27 family members. This mutation occurs at an evolutionarily conserved residue and is absent in the 1,140 ethnically matched control chromosomes. Genome-wide linkage study also supported its disease-causative role. Cell transfection studies showed that the TFG p.Gly269Val mutation increased the propensity of TFG proteins to form aggregates, resulting in sequestration of both mutant and wild-type TFG proteins and might thus deplete functional TFG molecules. The secreted Gaussia luciferase reporter assay demonstrated that inhibition of endogenous TFG compromised the protein secretion pathways, which could only be rescued by expressing wild-type TFG but not the p.Gly269Val altered proteins. TFG mutation was not found in 55 additional unrelated patients with CMT2, suggesting its rarity.
CONCLUSION: This study identifies a new cause of dominant CMT2 and highlights the importance of TFG in the protein secretory pathways that are essential for proper functioning of the human peripheral nervous system.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25098539     DOI: 10.1212/WNL.0000000000000758

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  R106C TFG variant causes infantile neuroaxonal dystrophy "plus" syndrome.

Authors:  A Catania; R Battini; T Pippucci; R Pasquariello; M L Chiapparini; M Seri; B Garavaglia; G Zorzi; N Nardocci; D Ghezzi; V Tiranti
Journal:  Neurogenetics       Date:  2018-07-03       Impact factor: 2.660

2.  A novel homozygous mutation of the TFG gene in a patient with early onset spastic paraplegia and later onset sensorimotor polyneuropathy.

Authors:  Takuya Miyabayashi; Tatsuhiro Ochiai; Naoki Suzuki; Masashi Aoki; Takehiko Inui; Yukimune Okubo; Ryo Sato; Noriko Togashi; Hiroshi Takashima; Hiroyuki Ishiura; Shoji Tsuji; Kishin Koh; Yoshihisa Takiyama; Kazuhiro Haginoya
Journal:  J Hum Genet       Date:  2018-11-22       Impact factor: 3.172

3.  TFG associated hereditary spastic paraplegia: an addition to the phenotypic spectrum.

Authors:  Huma Tariq; Sadaf Naz
Journal:  Neurogenetics       Date:  2017-01-25       Impact factor: 2.660

4.  TFG regulates secretory and endosomal sorting pathways in neurons to promote their activity and maintenance.

Authors:  Jennifer L Peotter; Iryna Pustova; Molly M Lettman; Shalini Shatadal; Mazdak M Bradberry; Allison D Winter-Reed; Maya Charan; Erin E Sharkey; James R Alvin; Alyssa M Bren; Annika K Oie; Edwin R Chapman; M Shahriar Salamat; Anjon Audhya
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

Review 5.  Clinical genetics of Charcot-Marie-Tooth disease.

Authors:  Yujiro Higuchi; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-03-18       Impact factor: 3.755

6.  The natural history of hereditary motor and sensory neuropathy with proximal dominant involvement (HMSN-P) in 97 Japanese patients.

Authors:  Natsumi Fujisaki; Shugo Suwazono; Masahito Suehara; Ryo Nakachi; Miwako Kido; Yoshihisa Fujiwara; Saki Oshiro; Takashi Tokashiki; Hiroshi Takashima; Masanori Nakagawa
Journal:  Intractable Rare Dis Res       Date:  2018-02

7.  TFG binds LC3C to regulate ULK1 localization and autophagosome formation.

Authors:  Francesca Nazio; Francesco Cecconi; Marianna Carinci; Beatrice Testa; Matteo Bordi; Giacomo Milletti; Massimo Bonora; Laura Antonucci; Caterina Ferraina; Marta Carro; Mukesh Kumar; Donatella Ceglie; Franziska Eck; Roberta Nardacci; Francois le Guerroué; Stefania Petrini; Maria E Soriano; Ignazio Caruana; Valentina Doria; Maria Manifava; Camille Peron; Matteo Lambrughi; Valeria Tiranti; Christian Behrends; Elena Papaleo; Paolo Pinton; Carlotta Giorgi; Nicholas T Ktistakis; Franco Locatelli
Journal:  EMBO J       Date:  2021-05-01       Impact factor: 11.598

8.  Two Novel De Novo GARS Mutations Cause Early-Onset Axonal Charcot-Marie-Tooth Disease.

Authors:  Yi-Chu Liao; Yo-Tsen Liu; Pei-Chien Tsai; Chia-Ching Chang; Yen-Hua Huang; Bing-Wen Soong; Yi-Chung Lee
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

9.  TFG Promotes Organization of Transitional ER and Efficient Collagen Secretion.

Authors:  Janine McCaughey; Victoria J Miller; Nicola L Stevenson; Anna K Brown; Annika Budnik; Kate J Heesom; Dominic Alibhai; David J Stephens
Journal:  Cell Rep       Date:  2016-05-12       Impact factor: 9.423

10.  Clinical and Molecular Characterization of BSCL2 Mutations in a Taiwanese Cohort with Hereditary Neuropathy.

Authors:  Cheng-Tsung Hsiao; Pei-Chien Tsai; Chou-Ching Lin; Yo-Tsen Liu; Yen-Hua Huang; Yi-Chu Liao; Han-Wei Huang; Kon-Ping Lin; Bing-Wen Soong; Yi-Chung Lee
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.